14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0200 $0.0500 Wednesday, 24th Apr 2024 CALA stock ended at $0.0200. This is 31.03% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 0% from a day low at $0.0200 to a day high of $0.0200.
90 days $0.0200 $0.120
52 weeks $0.0100 $0.500

Historical Calithera Biosciences prices

Date Open High Low Close Volume
Sep 21, 2021 $2.25 $2.31 $2.21 $2.24 401 554
Sep 20, 2021 $2.22 $2.28 $2.09 $2.18 746 108
Sep 17, 2021 $2.10 $2.27 $2.08 $2.27 1 057 663
Sep 16, 2021 $2.08 $2.08 $1.99 $2.05 1 102 245
Sep 15, 2021 $2.04 $2.17 $2.02 $2.10 487 249
Sep 14, 2021 $2.11 $2.17 $2.04 $2.05 364 751
Sep 13, 2021 $2.16 $2.20 $2.10 $2.11 624 024
Sep 10, 2021 $2.29 $2.32 $2.17 $2.19 680 217
Sep 09, 2021 $2.37 $2.37 $2.28 $2.29 341 922
Sep 08, 2021 $2.28 $2.36 $2.25 $2.35 438 884
Sep 07, 2021 $2.40 $2.47 $2.29 $2.30 500 198
Sep 03, 2021 $2.43 $2.46 $2.38 $2.40 222 559
Sep 02, 2021 $2.46 $2.49 $2.40 $2.43 397 684
Sep 01, 2021 $2.43 $2.48 $2.41 $2.42 193 893
Aug 31, 2021 $2.34 $2.45 $2.33 $2.45 439 864
Aug 30, 2021 $2.42 $2.48 $2.31 $2.36 383 357
Aug 27, 2021 $2.41 $2.46 $2.38 $2.40 387 593
Aug 26, 2021 $2.34 $2.42 $2.31 $2.38 743 438
Aug 25, 2021 $2.26 $2.38 $2.23 $2.33 507 820
Aug 24, 2021 $2.21 $2.30 $2.19 $2.26 790 539
Aug 23, 2021 $2.18 $2.26 $2.16 $2.20 484 928
Aug 20, 2021 $2.13 $2.22 $2.12 $2.15 712 479
Aug 19, 2021 $2.21 $2.22 $2.14 $2.15 439 237
Aug 18, 2021 $2.19 $2.25 $2.17 $2.21 288 775
Aug 17, 2021 $2.15 $2.24 $2.11 $2.21 451 092
Click to get the best stock tips daily for free!

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas... CALA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT